Alon Seifan

661 total citations
21 papers, 470 citations indexed

About

Alon Seifan is a scholar working on Psychiatry and Mental health, Physiology and General Health Professions. According to data from OpenAlex, Alon Seifan has authored 21 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 7 papers in Physiology and 5 papers in General Health Professions. Recurrent topics in Alon Seifan's work include Dementia and Cognitive Impairment Research (6 papers), Alzheimer's disease research and treatments (5 papers) and Diet and metabolism studies (3 papers). Alon Seifan is often cited by papers focused on Dementia and Cognitive Impairment Research (6 papers), Alzheimer's disease research and treatments (5 papers) and Diet and metabolism studies (3 papers). Alon Seifan collaborates with scholars based in United States, Netherlands and Israel. Alon Seifan's co-authors include Richard Isaacson, Matthew W. Schelke, Hilary Glazer, Christine Greer, Katherine Hackett, Christine A. Ganzer, Robert Krikorian, Aneela Rahman, Lisa Mosconi and Emily Caesar and has published in prestigious journals such as PLoS ONE, Neurology and Annals of the New York Academy of Sciences.

In The Last Decade

Alon Seifan

20 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alon Seifan United States 11 179 163 62 62 58 21 470
Olivia Scheyer United States 9 141 0.8× 179 1.1× 58 0.9× 73 1.2× 64 1.1× 11 549
Tan Zhao China 7 276 1.5× 183 1.1× 60 1.0× 104 1.7× 88 1.5× 11 663
Ross Penninkilampi Australia 8 189 1.1× 135 0.8× 42 0.7× 34 0.5× 56 1.0× 10 642
Nada Abdalla United States 5 224 1.3× 171 1.0× 37 0.6× 55 0.9× 57 1.0× 7 446
Dean Sherzai United States 14 231 1.3× 125 0.8× 79 1.3× 54 0.9× 50 0.9× 28 568
Christine A. Ganzer United States 14 212 1.2× 158 1.0× 53 0.9× 52 0.8× 64 1.1× 28 718
Katherine A. Lin United States 5 143 0.8× 168 1.0× 56 0.9× 35 0.6× 37 0.6× 13 425
Michelle R. Caunca United States 14 179 1.0× 180 1.1× 62 1.0× 99 1.6× 44 0.8× 34 700
Julien Delrieu France 14 298 1.7× 246 1.5× 81 1.3× 45 0.7× 46 0.8× 45 533
Johan Goeman Belgium 15 335 1.9× 239 1.5× 89 1.4× 71 1.1× 48 0.8× 21 580

Countries citing papers authored by Alon Seifan

Since Specialization
Citations

This map shows the geographic impact of Alon Seifan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alon Seifan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alon Seifan more than expected).

Fields of papers citing papers by Alon Seifan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alon Seifan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alon Seifan. The network helps show where Alon Seifan may publish in the future.

Co-authorship network of co-authors of Alon Seifan

This figure shows the co-authorship network connecting the top 25 collaborators of Alon Seifan. A scholar is included among the top collaborators of Alon Seifan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alon Seifan. Alon Seifan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ganzer, Christine A., et al.. (2019). Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Preventative Treatment of Episodic Migraine in Adults. Current Pain and Headache Reports. 23(11). 85–85. 24 indexed citations
2.
Seifan, Alon, Christine A. Ganzer, Krista Ryon, et al.. (2019). Detecting Non-cognitive Features of Prodromal Neurodegenerative Diseases. Current Aging Science. 11(4). 242–249. 10 indexed citations
3.
Seifan, Alon, Katherine Hackett, Matthew W. Schelke, et al.. (2018). Detection of neurodevelopmental diversity in memory clinics—Validation of a self-report measure. Research in Developmental Disabilities. 77. 60–67. 3 indexed citations
4.
Hackett, Katherine, Robert Krikorian, Tania Giovannetti, et al.. (2018). Utility of the NIH Toolbox for assessment of prodromal Alzheimer's disease and dementia. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 10(1). 764–772. 41 indexed citations
5.
Isaacson, Richard, Christine A. Ganzer, Hollie Hristov, et al.. (2018). The clinical practice of risk reduction for Alzheimer's disease: A precision medicine approach. Alzheimer s & Dementia. 14(12). 1663–1673. 76 indexed citations
6.
Isaacson, Richard, Alon Seifan, Candace L. Haddox, et al.. (2018). Using social media to disseminate education about Alzheimer’s prevention & treatment: a pilot study on Alzheimer's Universe (www.AlzU.org). Journal of Communications In Healthcare. 11(2). 106–113. 14 indexed citations
7.
Isaacson, Richard, Emily Caesar, Katherine Hackett, et al.. (2017). A Clinical Precision Medicine Approach Reduces Alzheimer’s, Dementia and Vascular Risk and Improves Cognition: A Prospective Cohort Study (P6.085). Neurology. 88(16_supplement). 1 indexed citations
8.
Seifan, Alon, Christine A. Ganzer, Françoise Vermeylen, et al.. (2016). Development and validation of the Alzheimer's prevention beliefs measure in a multi-ethnic cohort—a behavioral theory approach. Journal of Public Health. 39(4). 863–873. 10 indexed citations
9.
Schelke, Matthew W., Katherine Hackett, Christine A. Ganzer, et al.. (2016). Diagnosis of developmental learning and attention disorders in adults: A review of clinical modalities. Neurology Psychiatry and Brain Research. 23. 27–35. 7 indexed citations
10.
Isaacson, Richard, Jessica Gordon, & Alon Seifan. (2015). Validation of the Alzheimer’s Prevention and Risk Knowledge Score (APRKS) (s19.003). Neurology. 84(14_supplement).
11.
Seifan, Alon & Richard Isaacson. (2015). THE ALZHEIMER’S PREVENTION CLINIC AT WEILL CORNELL MEDICAL COLLEGE / NEW YORK - PRESBYTERIAN HOSPITAL: RISK STRATIFICATION AND PERSONALIZED EARLY INTERVENTION. The Journal of Prevention of Alzheimer s Disease. 2(4). 1–3. 17 indexed citations
12.
Seifan, Alon, et al.. (2015). Early Life Epidemiology of Alzheimer's Disease - A Critical Review. Neuroepidemiology. 45(4). 237–254. 80 indexed citations
13.
Seifan, Alon, Stephanie Assuras, Edward D. Huey, et al.. (2015). Childhood Learning Disabilities and Atypical Dementia: A Retrospective Chart Review. PLoS ONE. 10(6). e0129919–e0129919. 19 indexed citations
14.
Isaacson, Richard, Norris M. Haynes, Alon Seifan, et al.. (2014). ALZHEIMER’S PREVENTION EDUCATION: IF WE BUILD IT, WILL THEY COME? www.AlzU.org. The Journal of Prevention of Alzheimer s Disease. 1(2). 1–8. 9 indexed citations
15.
Seifan, Alon, Karen Marder, Jesse Mez, et al.. (2014). Hippocampal Laminar Distribution of Tau Relates to Alzheimer's Disease and Age of Onset. Journal of Alzheimer s Disease. 43(1). 315–324. 7 indexed citations
16.
Seifan, Alon, Morgan Mandigo, Raymond S. Price, et al.. (2013). Education Research: Can my electronic health record teach me something?. Neurology. 80(10). e98–e103. 4 indexed citations
17.
Glazer, Hilary, et al.. (2013). Alzheimer's Disease. Seminars in Neurology. 33(4). 313–329. 101 indexed citations
18.
19.
Shemer, Joshua, et al.. (2005). Medical technology management: bridging the gap between theory and practice.. PubMed. 7(4). 211–5. 5 indexed citations
20.
Seifan, Alon & Joshua Shemer. (2005). Economic evaluation of medical technologies.. PubMed. 7(2). 67–70. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olivia Scheyer Breakdown of academic impact, for papers by Tan Zhao Breakdown of academic impact, for papers by Ross Penninkilampi Breakdown of academic impact, for papers by Nada Abdalla Breakdown of academic impact, for papers by Dean Sherzai Breakdown of academic impact, for papers by Christine A. Ganzer Breakdown of academic impact, for papers by Katherine A. Lin Breakdown of academic impact, for papers by Michelle R. Caunca Breakdown of academic impact, for papers by Julien Delrieu Breakdown of academic impact, for papers by Johan Goeman
Rankless by CCL
2026